Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 142 No. 5152 (2012)

Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of cardiac comorbidity on surgical outcome

  • Omer Senbaklavaci
  • Hakan Taspinar
  • Marc Hartert
  • Sinem Ergun
  • Satu Keranen
  • Christian Friedrich Vahl
Cite this as:
Swiss Med Wkly. 2012;142:w13742


PRINCIPLES: The aim of this study was to evaluate the impact of cardiac comorbidity on the perioperative morbidity and mortality after lobar lung resection for lung cancer in patients aged 70 years and older.

METHODS: The medical records of all 68 patients ≥70 years, who underwent lobar lung resection for non-small cell lung cancer (NSCLC) from 2003 to 2011 at our department, were reviewed retrospectively. Twenty-two patients with a mean age of 76.3 years had cardiac comorbidities (Group A) including previous cardiac operations in 4 patients, previous myocardial infarction in 5 patients, previous coronary stent insertion in 3 patients, medically treated coronary artery disease in 10 patients and medically treated valvular heart disease in 2 patients whereas 46 patients (mean age = 74.5 years) had no previous cardiac history (Group B).

RESULTS: There were no significant differences in postoperative morbidity (13.6% in Group A vs. 17.4% in Group B) between both groups. No in-hospital mortality was observed in both groups.

CONCLUSION: In our experience lobar lung resections for NSCLC in elderly patients with cardiac comorbidity seem to be a safe therapy option for this increasing subpopulation. Though, our retrospective data with the small number of study objects require further confirmation in larger prospective trials.


  1. Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population based study. Lung Cancer. 1998;21:105–13.
  2. Murphy SL, Xu J, Kochanek KD. Deaths: Preliminary data for 2010. National Vital Statistics Report 2012;60:7.
  3. Suemitsu R, Takeo S, Hamatake M, Yoshino J, Motoyama M, Tanaka H. The perioperative complications for elderly patients with lung cancer associated with a pulmonary resection under general anesthesia, J Thorac Oncol. 2009;4:193–7.
  4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
  5. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89–92.
  6. Mishra PK, Pandey R, Shackcloth MJ, McShane J, Grayson AD, Carr MH, et al. Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer. Eur J Cardiothorac Surg. 2009;35:439–43.
  7. Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier JP, Varela G, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34:17–41.
  8. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation. 2007;116:e 418-e 500.
  9. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg. 2009;15:4–9.
  10. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, Sobin LH. In collaboration with Sobin LH and pathologists from 14 countries. World Health Organization international histological classification of tumours. Histological typing of lung and pleural tumours, 3rd Ed. Berlin: Springer-Verlag, 1999.
  12. Takamochi K, Oh S, Matsuoka J, Suzuki K. Risk factors for morbidity after pulmonary resection for lung cancer in younger and elderly patients. Interact CardioVasc Thorac Surg. 2011;12:739–43.
  13. Dyszkievics W, Pawlak K, Gasiorowski L. Early post-pneumonectomy complications in the elderly. Eur J Cardiothorac Surg. 2000;17:246–50.
  14. Pagni S, McKelvey A, Riordan C, Federico JA, Ponn RB. Pulmonary resection for malignancy in the elderly: is age still a sirk factor? Eur J Cardiothorac Surg. 1998;14:40–5.
  15. Moro-Sibilot D, Aubert A, Diab S, Lantuejoul S, Fourneret P, Brambilla E, et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J. 2005;26:480–6.
  16. Beshay M, Dorn P, Ris H-B, Schmid RA. Influence of comorbidity on outcome after pulmonary resection in the elderly. Asian Cardiovasc Thorac Ann. 2007;15:297–302.
  17. Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC, Deschamps C, Pairolero PC. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg. 2006;82:1175–9.
  18. Licker M, de Perrot M, Hohn L, Tschopp JM, Robert J, Fray JG, et al. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg. 1999;15:314–9.
  19. Ambrogi V, Pompeo E, Elia S, Pistolese GR, Mineo TC. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23:811–7.